There are 133 resources available
Trifluridine/tipiracil (TAS-102) with or without bevacizumab in patients with pretreated metastatic esophagogastric adenocarcinoma (mEGA): A Danish randomized trial (LonGas)
Presenter: Per Pfeiffer, Denmark
Session: Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
Resources:
Slides
Co-occurring HER2 and PD-L1 expression in patients with HER2-positive trastuzumab-refractory gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): biomarker analysis from the trastuzumab deruxtecan (T-DXd) DESTINY-Gastric03 trial
Presenter: Yelena Janjigian, United States
Session: Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
Resources:
Slides
Mentorship Part: Writing Your First Grant Application
Presenter: Joaquin Mateo, Spain
Session: Session IV: ESMO Session: Focus on Young Oncologists (YO) in Collaboration With ESMO Young Oncologist Committee (YOC)
Resources:
Slides
Soluble programmed cell death ligand 1 associated with clinical outcome in gastric cancer patients treated with nivolumab: Blood based biomarker analysis of DELIVER trial (JACCRO-GC08AR)
Presenter: Hisato Kawakami, Japan
Session: Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
Resources:
Slides
Discussant: O-3, O-4, SO-7, SO-8
Presenter: Kei Muro, Japan
Session: Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
Resources:
Slides
Pathological tumour and lymph node regression following neoadjuvant chemotherapy in resectable oesophagogastric cancer: Pooled analysis of 1619 patients from two randomised trial
Presenter: Avani Athauda, United Kingdom
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
The prognostic role of microarchitecture in tumour-positive lymph nodes in oesophageal cancer patients – results from the UK MRC OE02 trial
Presenter: Maximilian Kloft, Netherlands
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
Response evaluation after neoadjuvant chemotherapy for resectable gastric cancer; downsizing vs downstaging
Presenter: Alina Desiree Sandø, Norway
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
Discussant: SO-9, SO-10, SO-11
Presenter: Magali Svrcek, France
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
Debate: GE Junction Tumors: Neoadjuvant Chemoradiotherapy (CRT) or Perioperative Chemotherapy (CT) - PRO CRT
Presenter: David Ilson, United States
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides